Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Dianthus Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 166 | 2 | 241 | +77 |
| Shares | 49.1M | 2.28M | 62.2M | +15.4M (+32.8%) |
| Value | $2.02B | $93.9M | $5.18B | +$3.25B (+168.5%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (97)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (20)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Great Point Partners LLC | 350,000 | $14.4M |
| Public Sector Pension Investment Board | 48,477 | $2.00M |
| Two Sigma Investments, LP | 48,400 | $1.99M |
| Jane Street Group, LLC | 45,833 | $1.89M |
| Voloridge Investment Management, LLC | 39,480 | $1.63M |
| Renaissance Technologies LLC | 32,100 | $1.32M |
| Superstring Capital Management LP | 26,249 | $1.08M |
| Ishara Investments LP | 24,000 | $989.0K |
| Jain Global LLC | 23,694 | $976.4K |
| Two Sigma Advisers, LP | 22,000 | $906.6K |
| Lighthouse Investment Partners, LLC | 20,000 | $824.2K |
| Aquatic Capital Management LLC | 16,829 | $693.5K |
| Acuta Capital Partners, LLC | 16,708 | $688.5K |
| Fox Run Management, L.L.C. | 10,510 | $433.1K |
| Gsa Capital Partners LLP | 9,715 | $400.0K |
| Dark Forest Capital Management LP | 7,008 | $288.8K |
| Quarry LP | 2,400 | $98.9K |
| Quest Partners LLC | 1,856 | $76.5K |
| Amalgamated Bank | 769 | $32.0K |
| SageView Advisory Group, LLC | 7 | $289 |
Not filed for Q1 2026 yet (2)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,048,452 | $84.4M |
| Iron Triangle Partners LP | 230,730 | $9.51M |